BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 23828681)

  • 1. The role of ductus venosus Doppler flow in the diagnosis of chromosomal abnormalities during the first trimester of pregnancy.
    Florjański J; Fuchs T; Zimmer M; Homola W; Pomorski M; Blok D
    Adv Clin Exp Med; 2013; 22(3):395-401. PubMed ID: 23828681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
    Chen X; Chang Y; Cui HY; Ren CC; Yu BY
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ductus venosus in the first trimester: contribution to screening of chromosomal, cardiac defects and monochorionic twin complications.
    Maiz N; Nicolaides KH
    Fetal Diagn Ther; 2010; 28(2):65-71. PubMed ID: 20571255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal first-trimester ductus venosus blood flow: a marker of cardiac defects in fetuses with normal karyotype and nuchal translucency.
    Martínez JM; Comas M; Borrell A; Bennasar M; Gómez O; Puerto B; Gratacós E
    Ultrasound Obstet Gynecol; 2010 Mar; 35(3):267-72. PubMed ID: 20052662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
    Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
    Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation.
    Maiz N; Valencia C; Kagan KO; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2009 May; 33(5):512-7. PubMed ID: 19338027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-trimester screening for chromosomal abnormalities by integrated application of nuchal translucency, nasal bone, tricuspid regurgitation and ductus venosus flow combined with maternal serum free β-hCG and PAPP-A: a 5-year prospective study.
    Ghaffari SR; Tahmasebpour AR; Jamal A; Hantoushzadeh S; Eslamian L; Marsoosi V; Fattahi F; Rajaei M; Niroomanesh S; Borna S; Beigi A; Khazardoost S; Saleh-Gargari S; Rahimi-Sharbaf F; Farrokhi B; Bayani N; Tehrani SE; Shahsavan K; Farzan S; Moossavi S; Ramezanzadeh F; Dastan J; Rafati M
    Ultrasound Obstet Gynecol; 2012 May; 39(5):528-34. PubMed ID: 21793085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ductus venosus blood flow assessment at 11 to 14 weeks of gestation and fetal outcome.
    Toyama JM; Brizot ML; Liao AW; Lopes LM; Nomura RM; Saldanha FA; Zugaib M
    Ultrasound Obstet Gynecol; 2004 Apr; 23(4):341-5. PubMed ID: 15065182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.
    Nicolaides KH; Spencer K; Avgidou K; Faiola S; Falcon O
    Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of fetal nuchal translucency (NT) and ductus venosus blood flow (DV) in the detection of congenital heart defects].
    Baś-Budecka E; Perenc M; Sieroszewski P
    Ginekol Pol; 2010 Apr; 81(4):272-6. PubMed ID: 20476599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative and qualitative Ductus Venosus blood flow evaluation in the screening for Trisomy 18 and 13 - suitability study.
    Czuba B; Nycz-Reska M; Cnota W; Jagielska A; Wloch A; Borowski D; Wegrzyn P
    Ginekol Pol; 2020; 91(3):144-148. PubMed ID: 32266955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for aneuploidy in the first trimester by assessment of blood flow in the ductus venosus.
    Mavrides E; Sairam S; Hollis B; Thilaganathan B
    BJOG; 2002 Sep; 109(9):1015-9. PubMed ID: 12269675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome.
    Bilardo CM; Müller MA; Zikulnig L; Schipper M; Hecher K
    Ultrasound Obstet Gynecol; 2001 Apr; 17(4):288-94. PubMed ID: 11339183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the ductus venosus, tricuspid blood flow and the nasal bone in second-trimester screening for trisomy 21.
    Stressig R; Kozlowski P; Froehlich S; Siegmann HJ; Hammer R; Blumenstock G; Kagan KO
    Ultrasound Obstet Gynecol; 2011 Apr; 37(4):444-9. PubMed ID: 20645398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-trimester screening for chromosomal abnormalities.
    Nicolaides KH
    Semin Perinatol; 2005 Aug; 29(4):190-4. PubMed ID: 16104667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved diagnostic accuracy by using secondary ultrasound markers in the first-trimester screening for trisomies 21, 18 and 13 and Turner syndrome.
    Karadzov-Orlic N; Egic A; Milovanovic Z; Marinkovic M; Damnjanovic-Pazin B; Lukic R; Joksic I; Curkovic A; Mikovic Z
    Prenat Diagn; 2012 Jul; 32(7):638-43. PubMed ID: 22570267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ductus venosus blood flow in chromosomally abnormal fetuses at 11 to 14 weeks of gestation.
    Matias A; Montenegro N
    Semin Perinatol; 2001 Feb; 25(1):32-7. PubMed ID: 11254158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal ductus venosus flow and tricuspid regurgitation at 11-14 weeks' gestation have high positive predictive values for increased risk in first-trimester combined screening test: results of a pilot study.
    Ozkaya O; Sezik M; Ozbasar D; Kaya H
    Taiwan J Obstet Gynecol; 2010 Jun; 49(2):145-50. PubMed ID: 20708518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role for fetal ductus venosus and hepatic artery Doppler in screening for fetal aneuploidy in the first trimester?
    Togrul C; Ozaksit GM; Seckin KD; Baser E; Karsli MF; Gungor T
    J Matern Fetal Neonatal Med; 2015; 28(14):1716-9. PubMed ID: 25231598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal first-trimester ductus venosus blood flow: a risk factor for adverse outcome in fetuses with normal nuchal translucency.
    Oh C; Harman C; Baschat AA
    Ultrasound Obstet Gynecol; 2007 Aug; 30(2):192-6. PubMed ID: 17518423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.